New drug duo tested in fight against advanced liver cancer
NCT ID NCT03519997
Summary
This study is testing whether a combination of two drugs, pembrolizumab and bavituximab, can help control advanced liver cancer (hepatocellular carcinoma). It is for patients whose cancer cannot be treated with surgery or localized therapies and who have not yet received other drug treatments for their advanced disease. The main goal is to see how many patients' tumors shrink or disappear in response to this combination therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Parkland Health & Hospital System
Dallas, Texas, 75235, United States
-
University of Texas Southwestern Medical Center
Dallas, Texas, 75390, United States
Conditions
Explore the condition pages connected to this study.